HZNP

Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP

Overview Fund Activity
Delisted

HZNP was delisted on the 5th of October, 2023.

Back to rankings

295 hedge funds and large institutions have $5.24B invested in Horizon Therapeutics Public Limited Company Ordinary Shares in 2020 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 98 increasing their positions, 114 reducing their positions, and 38 closing their positions.

Holders
295
Holders Change
+14
Holders Change %
+4.98%
% of All Funds
6.52%
Holding in Top 10
17
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+6.25%
% of All Funds
0.38%
New
55
Increased
98
Reduced
114
Closed
38
Calls
$14.2M
Puts
$11.7M
Net Calls
+$2.47M
Net Calls Change
-$6.31M

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$107M
2
Viking Global Investors
2
Viking Global Investors
Connecticut
$59M
3
Victory Capital Management
3
Victory Capital Management
Texas
$89.1M
4
DM
4
Deerfield Management
New York
$174M
5
Allianz Asset Management
5
Allianz Asset Management
Germany
$61.1M

Top Sellers

1
SCM
1
Scopia Capital Management
New York
$37.5M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$0
3
Ameriprise
3
Ameriprise
Minnesota
$60.4M
4
BGIM
4
Brandywine Global Investment Management
Pennsylvania
$1.1M
5
WP
5
Woodline Partners
California
$37.7M
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$520M 17,544,776 +455,362 +3%
Renaissance Technologies
2
Renaissance Technologies
New York
$315M 10,623,675 +523,000 +5%
BlackRock
3
BlackRock
New York
$304M 10,261,071 -94,388 -0.9%
William Blair Investment Management
4
William Blair Investment Management
Illinois
$246M 8,319,945 -535,545 -6%
PC
5
Paulson & Co
New York
$242M 8,170,700 – –
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$198M 6,682,922 +807,303 +14%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$177M 5,970,913 -571,448 -9%
DM
8
Deerfield Management
New York
$174M 5,888,511 +1,146,200 +24%
ACA
9
Avoro Capital Advisors
New York
$136M 4,575,000 +575,000 +14%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$128M 4,317,753 -816,404 -16%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$124M 4,201,388 -480,575 -10%
JPMorgan Chase & Co
12
JPMorgan Chase & Co
New York
$122M 4,134,098 +389,654 +10%
Citadel Advisors
13
Citadel Advisors
Florida
$107M 3,597,652 +2,230,627 +163%
Victory Capital Management
14
Victory Capital Management
Texas
$89.1M 3,008,876 +1,453,060 +93%
Invesco
15
Invesco
Georgia
$86.4M 2,918,086 -571,622 -16%
PC
16
Polar Capital
United Kingdom
$79.3M 2,676,492 +517,236 +24%
State Street
17
State Street
Massachusetts
$78.9M 2,664,837 +67,327 +3%
O
18
OrbiMed
New York
$69.4M 2,341,700 +759,400 +48%
Aberdeen Group
19
Aberdeen Group
United Kingdom
$67.2M 2,269,518 +429,800 +23%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$65.6M 2,214,031 +91,168 +4%
Nuveen Asset Management
21
Nuveen Asset Management
Illinois
$62.8M 2,121,788 -768,123 -27%
Norges Bank
22
Norges Bank
Norway
$62.3M 2,104,185 +5,994 +0.3%
Allianz Asset Management
23
Allianz Asset Management
Germany
$61.1M 2,063,543 +908,002 +79%
Ameriprise
24
Ameriprise
Minnesota
$60.4M 2,039,183 -1,218,599 -37%
Jennison Associates
25
Jennison Associates
New York
$59.1M 1,995,141 +37,787 +2%
1
2 3 4 5